respiratory emergency
Pulmonary Embolism Severity Index (PESI) -- Full Version
Full PESI score predicts 30-day mortality in acute pulmonary embolism. Classifies patients into 5 risk classes (I-V) based on age, sex, cancer, heart failure, COPD, heart rate, systolic BP, respiratory rate, temperature, mental status, and O2 saturation. Risk Class I-II (very low/low) may be suitable for outpatient treatment with DOAC. Validated in 11,000+ patients. Note: simplified PESI (sPESI) also available in this app.
References
- Aujesky D et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041-1046.
- Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41(4):543-603.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Composite Pulmonary Embolism Shock (CPES) Score · Pulmonary Embolism
- Pulmonary Embolism Severity Index (PESI) · Pulmonary Embolism
- YEARS Algorithm for Pulmonary Embolism · Pulmonary Embolism
- Wells' Criteria for Pulmonary Embolism · Pulmonary Embolism
- Revised Geneva Score for Pulmonary Embolism · Pulmonary Embolism
- Bova Score for Pulmonary Embolism Complications · Pulmonary Embolism
Drugs
- Lidocaine (IV — Anaesthesia/ICU) · Local Anaesthetic / Antiarrhythmic (Class Ib)
- Amiodarone (IV — ICU/Peri-Arrest) · Antiarrhythmic (Class III)
- Nitric Oxide (Inhaled — iNO) · Selective Pulmonary Vasodilator
- Lidocaine hydrochloride · Amide local anaesthetic / Class IB antiarrhythmic
- Flecainide · Class IC Antiarrhythmic
- Alteplase (STEMI Thrombolysis) · Thrombolytic / STEMI
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.